MedTrace Logo

Efficacy and Safety of NEM® Brand Eggshell Membrane in Patients With Grade 2/3 Knee Osteoarthritis

NCT02291757 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2018-08-22

No results posted yet for this study

Summary

This study was designed to evaluate the efficacy and safety of NEM® brand eggshell membrane in patients with grades 2 and 3 knee osteoarthritis (OA) having significant joint pain and stiffness, in a large, multi-center clinical trial.

Conditions

  • Osteoarthritis, Knee

Interventions

DIETARY_SUPPLEMENT

NEM brand eggshell membrane

NEM 500 mg, once daily, p.o.

DIETARY_SUPPLEMENT

Placebo

Placebo, 500 mg, once daily, p.o.

Sponsors & Collaborators

  • Optimum Contract Research Organisation

    collaborator UNKNOWN

  • Generica Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Meltem Çakmakgil, Dr. · Generica Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02291757 on ClinicalTrials.gov